Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Blood Neoplasia|September 15, 2025
Clarithromycin, ixazomib, pomalidomide, dexamethasone for relapsed/refractory myeloma: survival and correlative analysisAaron S Rosenberg, Emanual Maverakis, Caitlin Costello, et al.Hepatology (Baltimore, Md.)|October 31, 2009
B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative miceYuki Moritoki, Zhe-Xiong Lian, Keith Lindor, et al.Clinical Lymphoma, Myeloma & Leukemia|June 19, 2023
Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective AnalysisTamer Othman, Michelle A Quan, Shiliang Zhang, et al.Clinical Lymphoma, Myeloma & Leukemia|July 20, 2022
R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective AnalysisTamer Othman, Juan Penaloza, Shiliang Zhang, et al.Communications Biology|December 3, 2021
KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growthMichiko Shimoda, Yuanzhi Lyu, Kang-Hsin Wang, et al.Haematologica|July 18, 2024
Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphomaTamer Othman, Paul Frankel, Pamela Allen, et al.Cancer Journal (Sudbury, Mass.)|November 9, 2004
An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in CaliforniaCynthia L Martel, Yueju Li, Laurel Beckett, et al.Haematologica|June 24, 2021
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 studyAndrew M Evens, Joseph M Connors, Anas Younes, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021Andrew D Zelenetz, Leo I Gordon, Julie E Chang, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 9, 2025
NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, et al.Pageof 4